Oculus device receives FDA premarket approval

Lynwood, WA-The FDA has granted premarket approval to a new pachymeter/auto-refractor/keratometer (PARK 1, Oculus). The device will be launched at the annual meeting of the American Academy of Ophthalmology in Atlanta.

The instrument is designed to photograph the eye and obtain a Scheimpflug image of the cornea to evaluate its thickness. The implanted ophthalmic refractometer measures the refractive power of the eye.